The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/ pharmaceutical (BCP) customer partnership meeting to be held on September 13, 2011. The proposed agenda is as follows:
Morning Session
• Greetings, TC Update, and Overview (10:00 - 10:15 am EDT): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600
• PCT Sequence Rule Compliance in U.S. National Phase Applications (10:15 - 11:15 am): Sue Wolski, Office of PCT Legal Administration
• Break (11:15 - 11:30 am)
• Enhancing Compact Prosecution at BPAI (11:30 am - 12:30 pm): Joe Mallon, Knobbe, Martens, Olson and Bear, LLP
• Lunch (12:30 – 1:30 pm)
Afternoon Session
• Supplemental 112/2 Examination Guidelines (1:30 - 2:30 pm): Kathleen Fonda, Office of Patent Legal Administration
• Break (2:30 - 2:45 pm)
• The Myriad case (Association for Molecular Pathology v. USPTO) and Its Implications for Patent Practitioners and the Biotech Industry (2:45 - 3:45 pm): Robert Makowski, Ph.D., J.D., Connolly Bove Lodge & Hutz LLP
• Common Issues Examiners Face Regarding PLT and Plant Utility Patents (3:45 - 4:30 pm): Anne Marie Grunberg, SPE, Art Unit 1638/1661
• Closing Remarks/Discussion (4:30 - 4:45 pm): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600
The meeting can be attended in person at the USPTO's Auditorium in Madison East, 600 Dulany Street, Alexandria, VA, or viewed online here (select the "enter as guest" option). The Patent Office asks that non-USPTO employees login using their e-mail addresses. Those wishing to attend the meeting should contact Cecilia Tsang by phone at 571-272-0562, by fax at 571-273-0562, or by e-mail at [email protected] by September 8, 2011 to confirm their attendance. Additional information regarding the BCP customer partnership meeting can be found here.
Comments